Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), Julie Eastland, President and Chief Executive Officer of Harpoon Therapeutics, Inc. (the “Company”), and Georgia Erbez, Chief Financial Officer of the Company, each hereby certifies that, to the best of her knowledge:
IN WITNESS WHEREOF, the undersigned have set their hands hereto as of the 10th day of March, 2022.
Date: March 10, 2022 |
| By: |
| /s/ Julie Eastland |
|
|
|
| Julie Eastland |
|
|
|
| President and Chief Executive Officer |
Date: March 10, 2022 |
| By: |
| /s/ Georgia Erbez |
|
|
|
| Georgia Erbez |
|
|
|
| Chief Financial Officer |